Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Ena-DATASET-CRICK-26-02-2019-16:59:18:134-76 - samples

ABSTRACT: TRACERx 100: RRBS data from a subset of the first 100 TRACERx tumours

PROVIDER: EGAD00001004798 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

ena-DATASET-CRICK-01-02-2019-13:45:41:379-54 - samples

Project description:TRACERx 100: RNAseq data from the first 100 TRACERx tumours (164 tumor regions from 64 patients)

| EGAD00001004591 | EGA

ena-DATASET-CRICK-26-06-2017-15:25:44:436-300 - samples

Project description:RRBS sequencing of 7 tumour regions and a normal sample from a single TRACERx patient.

| EGAD00001003404 | EGA

Human esophageal dysplasia (16 cases) vs. esophageal squamous cell carcinoma (59 cases)

Project description:Our aim is to identify frequent genomic aberrations both in ESCC and esophageal dysplasia, and to discover important copy number-driving genes and microRNAs in ESCC. We carried out array-based comparative genomic hybridization (array CGH) on 59 ESCC resection samples and 16 dysplasia biopsy samples. Expression of genes at 11q13.3 was analyzed by real-time PCR and immunohistochemistry (IHC). Integrated analysis was performed to identify genes or microRNAs with copy number-expression correlations.

2013-04-29 | GSE46452 | GEO

In vitro and in vivo transcriptome analysis of CT-26 and Colon 26 tumor models

Project description:To determine the transcriptomic differences between CT-26 and Colon 26, we sequenced RNA from these cell lines as well as tumors isolated ex vivo from tumor bearing animals at sizes 100, 400 and 800 mm3

2021-11-08 | GSE185023 | GEO

ena-DATASET-RUNMC-21-10-2013-16:26:59:417-6 - samples

Project description:Single end short-read (50 bp) SOLiD 4 sequencing data for 300 individuals, constituting 100 patient-parent trios. For more details please read; http://www.nejm.org/doi/full/10.1056/NEJMoa1206524

| EGAD00001000680 | EGA

Differences in the Synthesis and Elimination of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 After Acute Doses of Alcohol.

Project description: Not available

| S-EPMC5915873 | biostudies-literature

Human esophageal dysplasia (16 cases) vs. esophageal squamous cell carcinoma (59 cases)

2013-04-29 | E-GEOD-46452 | biostudies-arrayexpress

Strong Time Dependence of the 76-Gene Prognostic Signature

Project description:Background: Recently a 76-gene prognostic signature able to predict distant metastases in lymph node-negative (N-) breast cancer patients was reported. The aims of this study conducted by TRANSBIG were to independently validate these results and to compare the outcome with clinical risk assessment. Materials and Methods: Gene expression profiling of frozen samples from 198 N- systemically untreated patients was performed at the Bordet Institute, blinded to clinical data and independent of Veridex. Genomic risk was defined by Veridex, blinded to clinical data. Survival analyses, done by an independent statistician, were performed with the genomic risk and adjusted for the clinical risk, defined by Adjuvant!Online. Results: The actual 5- and 10-year time to distant metastasis (TDM) were 98% (88%-100%) and 94% (83%-98%) respectively for the good profile group and 76% (68%- 82%) and 73% (65%-79%) for the poor profile group. The actual 5- and 10-year overall survival (OS) were 98% (88%-100%) and 87% (73%-94%) respectively for the good profile group and 84% (77%-89%) and 72% (63%-78%) for the poor profile group. We observed a strong time-dependency of this signature, leading to an adjusted HR of 13.58 (1.85-99.63) and 8.20 (1.10-60.90) at 5 years, and 5.11 (1.57-16.67) and 2.55 (1.07-6.10) at 10 years for TDM and OS respectively. Conclusion: This independent validation confirmed the performance of the 76-gene signature and adds to the growing evidence that gene expression signatures are of clinical relevance, especially for identifying patients at high risk of early distant metastases. Keywords: disease state analysis

2007-06-11 | GSE7390 | GEO

Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26-February 16, 2021.

Project description: Not available

| S-EPMC8084510 | biostudies-literature